CN Stock MarketDetailed Quotes

688566 Jiangsu Jibeier Pharmaceutical Co., Ltd.

Watchlist
  • 21.19
  • +0.67+3.27%
Noon Break Aug 30 11:29 CST
4.16BMarket Cap17.01P/E (TTM)

Jiangsu Jibeier Pharmaceutical Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
3.55%433.66M
17.47%194.23M
31.49%860.93M
44.64%616.97M
62.83%418.81M
19.10%165.34M
28.46%654.73M
16.29%426.57M
2.56%257.21M
15.61%138.82M
Operating revenue
3.55%433.66M
17.47%194.23M
31.49%860.93M
44.64%616.97M
62.83%418.81M
19.10%165.34M
28.46%654.73M
16.29%426.57M
2.56%257.21M
15.61%138.82M
Total operating cost
-3.51%291.52M
9.25%134.01M
24.26%609.49M
25.47%431.84M
38.01%302.13M
15.61%122.67M
22.36%490.5M
18.24%344.19M
10.30%218.92M
16.34%106.11M
Operating cost
-3.36%44.9M
3.48%20.43M
24.93%95.15M
34.02%68.59M
46.14%46.45M
23.39%19.75M
22.62%76.17M
13.78%51.18M
5.91%31.79M
15.68%16M
Operating tax surcharges
40.82%6.35M
127.05%2.87M
13.36%10.47M
41.74%7.27M
17.09%4.51M
-34.25%1.26M
1.57%9.24M
-25.61%5.13M
-17.73%3.85M
-16.83%1.92M
Operating expense
-1.70%196.85M
10.38%87.66M
29.26%401.87M
31.27%280.73M
50.88%200.24M
10.79%79.42M
19.51%310.91M
14.25%213.85M
4.05%132.72M
16.14%71.68M
Administration expense
3.68%28.8M
-0.81%14.03M
14.49%57.99M
9.78%42.08M
8.91%27.77M
31.17%14.14M
13.85%50.65M
22.27%38.33M
21.22%25.5M
23.84%10.78M
Financial expense
49.26%-2.77M
-53.69%-673.78K
-1.16%-11.78M
-45.52%-8.93M
-32.24%-5.46M
66.55%-438.4K
-172.37%-11.65M
-97.23%-6.13M
-129.32%-4.13M
-57.70%-1.31M
-Interest expense (Financial expense)
24.36%79.66K
-93.44%56.77K
-71.95%105.53K
-62.09%65.44K
-62.89%64.06K
--865.17K
--376.23K
--172.62K
--172.62K
----
-Interest Income (Financial expense)
47.71%-2.91M
42.95%-758.2K
0.54%-12.02M
-43.15%-9.1M
-28.77%-5.57M
-0.31%-1.33M
-175.93%-12.09M
-98.74%-6.35M
-132.55%-4.33M
-53.06%-1.33M
Research and development
-39.17%17.4M
13.62%9.7M
1.08%55.77M
0.63%42.1M
-2.01%28.6M
21.42%8.53M
88.44%55.18M
75.68%41.83M
71.90%29.19M
28.64%7.03M
Credit Impairment Loss
76.23%-1.82M
142.42%827.87K
-883.43%-7.2M
-181.27%-6.27M
-318.95%-7.66M
-572.97%-1.95M
-141.40%-732.27K
-37.57%-2.23M
-757.48%-1.83M
-145.23%-289.98K
Asset Impairment Loss
----
----
---2.02M
----
----
----
----
----
----
----
Other net revenue
Invest income
-37.40%-1.95M
-157.64%-2.14M
-133.46%-1.9M
-196.19%-2.83M
-136.20%-1.42M
-101.83%-828.72K
-67.08%5.68M
-69.65%2.94M
-51.48%3.92M
---410.6K
-Including: Investment income associates
3.65%-2.4M
-28.96%-1.4M
8.78%-5.55M
13.23%-3.97M
18.93%-2.49M
29.29%-1.09M
-80.34%-6.09M
-4,200.51%-4.58M
---3.07M
---1.54M
Asset deal income
----
----
----
----
----
----
----
---9.79K
----
----
Other revenue
250.06%1.53M
211.45%721.14K
21.73%8.79M
-82.76%1.08M
-92.21%436.24K
-56.05%231.54K
24.95%7.22M
34.73%6.27M
152.65%5.6M
-72.20%526.8K
Operating profit
29.48%139.89M
48.62%59.63M
41.22%249.11M
98.23%177.12M
134.96%108.04M
23.31%40.13M
32.00%176.4M
1.03%89.35M
-26.91%45.98M
3.61%32.54M
Add:Non operating Income
--7.2K
----
-92.49%458.64
----
----
----
--6.1K
--1.5K
--1.5K
----
Less:Non operating expense
50.73%475.35K
-10.68%144.53K
-12.61%1.64M
-66.01%449.76K
104.36%315.36K
607.54%161.8K
74.71%1.87M
53.83%1.32M
-61.54%154.32K
-93.88%22.87K
Total profit
29.43%139.43M
48.86%59.49M
41.79%247.48M
100.69%176.67M
135.05%107.72M
22.90%39.96M
31.66%174.53M
0.52%88.03M
-26.69%45.83M
4.79%32.52M
Less:Income tax cost
50.92%17.59M
243.47%7.06M
41.63%28.71M
140.79%21.88M
196.55%11.65M
-49.17%2.06M
11.29%20.27M
-22.71%9.09M
-45.40%3.93M
-5.21%4.04M
Net profit
26.82%121.84M
38.31%52.43M
41.81%218.77M
96.08%154.79M
129.28%96.07M
33.14%37.91M
34.91%154.26M
4.12%78.94M
-24.25%41.9M
6.38%28.47M
Net profit from continuing operation
26.82%121.84M
38.31%52.43M
41.81%218.77M
96.08%154.79M
129.28%96.07M
33.14%37.91M
34.91%154.26M
4.12%78.94M
-24.25%41.9M
6.38%28.47M
Less:Minority Profit
12.88%-167.19K
17.92%-84.48K
20.87%-320.31K
11.08%-279.55K
9.07%-191.9K
8.40%-102.93K
26.96%-404.79K
26.57%-314.38K
36.71%-211.04K
47.81%-112.36K
Net profit of parent company owners
26.74%122.01M
38.15%52.51M
41.65%219.09M
95.65%155.07M
128.59%96.26M
32.98%38.01M
34.61%154.67M
3.94%79.26M
-24.33%42.11M
5.95%28.58M
Earning per share
Basic earning per share
27.45%0.65
40.00%0.28
40.96%1.17
97.62%0.83
121.74%0.51
33.33%0.2
36.07%0.83
2.44%0.42
-23.33%0.23
7.14%0.15
Diluted earning per share
27.45%0.65
40.00%0.28
40.96%1.17
97.62%0.83
121.74%0.51
33.33%0.2
36.07%0.83
2.44%0.42
-23.33%0.23
7.14%0.15
Other composite income
Total composite income
26.82%121.84M
38.31%52.43M
41.81%218.77M
96.08%154.79M
129.28%96.07M
33.14%37.91M
34.91%154.26M
4.12%78.94M
-24.25%41.9M
6.38%28.47M
Total composite income of parent company owners
26.74%122.01M
38.15%52.51M
41.65%219.09M
95.65%155.07M
128.59%96.26M
32.98%38.01M
34.61%154.67M
3.94%79.26M
-24.33%42.11M
5.95%28.58M
Total composite income of minority owners
12.88%-167.19K
17.92%-84.48K
20.87%-320.31K
11.08%-279.55K
9.07%-191.9K
8.40%-102.93K
26.96%-404.79K
26.57%-314.38K
36.71%-211.04K
47.81%-112.36K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 3.55%433.66M17.47%194.23M31.49%860.93M44.64%616.97M62.83%418.81M19.10%165.34M28.46%654.73M16.29%426.57M2.56%257.21M15.61%138.82M
Operating revenue 3.55%433.66M17.47%194.23M31.49%860.93M44.64%616.97M62.83%418.81M19.10%165.34M28.46%654.73M16.29%426.57M2.56%257.21M15.61%138.82M
Total operating cost -3.51%291.52M9.25%134.01M24.26%609.49M25.47%431.84M38.01%302.13M15.61%122.67M22.36%490.5M18.24%344.19M10.30%218.92M16.34%106.11M
Operating cost -3.36%44.9M3.48%20.43M24.93%95.15M34.02%68.59M46.14%46.45M23.39%19.75M22.62%76.17M13.78%51.18M5.91%31.79M15.68%16M
Operating tax surcharges 40.82%6.35M127.05%2.87M13.36%10.47M41.74%7.27M17.09%4.51M-34.25%1.26M1.57%9.24M-25.61%5.13M-17.73%3.85M-16.83%1.92M
Operating expense -1.70%196.85M10.38%87.66M29.26%401.87M31.27%280.73M50.88%200.24M10.79%79.42M19.51%310.91M14.25%213.85M4.05%132.72M16.14%71.68M
Administration expense 3.68%28.8M-0.81%14.03M14.49%57.99M9.78%42.08M8.91%27.77M31.17%14.14M13.85%50.65M22.27%38.33M21.22%25.5M23.84%10.78M
Financial expense 49.26%-2.77M-53.69%-673.78K-1.16%-11.78M-45.52%-8.93M-32.24%-5.46M66.55%-438.4K-172.37%-11.65M-97.23%-6.13M-129.32%-4.13M-57.70%-1.31M
-Interest expense (Financial expense) 24.36%79.66K-93.44%56.77K-71.95%105.53K-62.09%65.44K-62.89%64.06K--865.17K--376.23K--172.62K--172.62K----
-Interest Income (Financial expense) 47.71%-2.91M42.95%-758.2K0.54%-12.02M-43.15%-9.1M-28.77%-5.57M-0.31%-1.33M-175.93%-12.09M-98.74%-6.35M-132.55%-4.33M-53.06%-1.33M
Research and development -39.17%17.4M13.62%9.7M1.08%55.77M0.63%42.1M-2.01%28.6M21.42%8.53M88.44%55.18M75.68%41.83M71.90%29.19M28.64%7.03M
Credit Impairment Loss 76.23%-1.82M142.42%827.87K-883.43%-7.2M-181.27%-6.27M-318.95%-7.66M-572.97%-1.95M-141.40%-732.27K-37.57%-2.23M-757.48%-1.83M-145.23%-289.98K
Asset Impairment Loss -----------2.02M----------------------------
Other net revenue
Invest income -37.40%-1.95M-157.64%-2.14M-133.46%-1.9M-196.19%-2.83M-136.20%-1.42M-101.83%-828.72K-67.08%5.68M-69.65%2.94M-51.48%3.92M---410.6K
-Including: Investment income associates 3.65%-2.4M-28.96%-1.4M8.78%-5.55M13.23%-3.97M18.93%-2.49M29.29%-1.09M-80.34%-6.09M-4,200.51%-4.58M---3.07M---1.54M
Asset deal income -------------------------------9.79K--------
Other revenue 250.06%1.53M211.45%721.14K21.73%8.79M-82.76%1.08M-92.21%436.24K-56.05%231.54K24.95%7.22M34.73%6.27M152.65%5.6M-72.20%526.8K
Operating profit 29.48%139.89M48.62%59.63M41.22%249.11M98.23%177.12M134.96%108.04M23.31%40.13M32.00%176.4M1.03%89.35M-26.91%45.98M3.61%32.54M
Add:Non operating Income --7.2K-----92.49%458.64--------------6.1K--1.5K--1.5K----
Less:Non operating expense 50.73%475.35K-10.68%144.53K-12.61%1.64M-66.01%449.76K104.36%315.36K607.54%161.8K74.71%1.87M53.83%1.32M-61.54%154.32K-93.88%22.87K
Total profit 29.43%139.43M48.86%59.49M41.79%247.48M100.69%176.67M135.05%107.72M22.90%39.96M31.66%174.53M0.52%88.03M-26.69%45.83M4.79%32.52M
Less:Income tax cost 50.92%17.59M243.47%7.06M41.63%28.71M140.79%21.88M196.55%11.65M-49.17%2.06M11.29%20.27M-22.71%9.09M-45.40%3.93M-5.21%4.04M
Net profit 26.82%121.84M38.31%52.43M41.81%218.77M96.08%154.79M129.28%96.07M33.14%37.91M34.91%154.26M4.12%78.94M-24.25%41.9M6.38%28.47M
Net profit from continuing operation 26.82%121.84M38.31%52.43M41.81%218.77M96.08%154.79M129.28%96.07M33.14%37.91M34.91%154.26M4.12%78.94M-24.25%41.9M6.38%28.47M
Less:Minority Profit 12.88%-167.19K17.92%-84.48K20.87%-320.31K11.08%-279.55K9.07%-191.9K8.40%-102.93K26.96%-404.79K26.57%-314.38K36.71%-211.04K47.81%-112.36K
Net profit of parent company owners 26.74%122.01M38.15%52.51M41.65%219.09M95.65%155.07M128.59%96.26M32.98%38.01M34.61%154.67M3.94%79.26M-24.33%42.11M5.95%28.58M
Earning per share
Basic earning per share 27.45%0.6540.00%0.2840.96%1.1797.62%0.83121.74%0.5133.33%0.236.07%0.832.44%0.42-23.33%0.237.14%0.15
Diluted earning per share 27.45%0.6540.00%0.2840.96%1.1797.62%0.83121.74%0.5133.33%0.236.07%0.832.44%0.42-23.33%0.237.14%0.15
Other composite income
Total composite income 26.82%121.84M38.31%52.43M41.81%218.77M96.08%154.79M129.28%96.07M33.14%37.91M34.91%154.26M4.12%78.94M-24.25%41.9M6.38%28.47M
Total composite income of parent company owners 26.74%122.01M38.15%52.51M41.65%219.09M95.65%155.07M128.59%96.26M32.98%38.01M34.61%154.67M3.94%79.26M-24.33%42.11M5.95%28.58M
Total composite income of minority owners 12.88%-167.19K17.92%-84.48K20.87%-320.31K11.08%-279.55K9.07%-191.9K8.40%-102.93K26.96%-404.79K26.57%-314.38K36.71%-211.04K47.81%-112.36K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg